Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1092498 | 0.90 | — | — | |
| SCHEMBL19316268 | 0.90 | — | — | |
| SCHEMBL26643162 | 0.90 | LMNA (0.48) | LMNABLM | |
| SCHEMBL10206065 | 0.90 | — | — | |
| SCHEMBL15849724 | 0.86 | LMNA (0.37) | LMNA | |
| SCHEMBL16104065 | 0.85 | — | — | |
| SCHEMBL10041494 | 0.83 | LMNA (0.62) | LMNABLM | |
| SCHEMBL22015868 | 0.83 | LMNA (0.62) | LMNABLM | |
| SCHEMBL13590014 | 0.83 | LMNA (0.62) | LMNABLM | |
| SCHEMBL20223357 | 0.83 | ACE2 (0.38) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114502604-A | Process for polymerizing polypropylene using ziegler-natta procatalyst with novel 1, 3-diether internal electron donor | SABIC环球技术有限责任公司 | 2022-05-13 | — | — | CN | claimed |
| CN-114502604-A | Process for polymerizing polypropylene using ziegler-natta procatalyst with novel 1, 3-diether internal electron donor | SABIC环球技术有限责任公司 | 2022-05-13 | — | — | CN | disclosed |
| US-8969406-B2 | Use of compound for inhibiting glutathione s-transferase omega 1 activity and method for synthesizing the same | CHINA MEDICAL UNIVERSITY (TW) | 2015-03-03 | — | — | US | disclosed |
| US-8969406-B2 | Use of compound for inhibiting glutathione s-transferase omega 1 activity and method for synthesizing the same | CHINA MEDICAL UNIVERSITY (TW) | 2015-03-03 | — | — | US | disclosed |
| US-20140221470-A1 | COMPOUND FOR INHIBITING GLUTATHIONE S-TRANSFERASE OMEGA 1 ACTIVITY, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, AND METHOD FOR SYNTHESIZING THE SAME | CHINA MEDICAL UNIVERSITY (TW) | 2014-08-07 | — | — | US | disclosed |
| US-20140221470-A1 | COMPOUND FOR INHIBITING GLUTATHIONE S-TRANSFERASE OMEGA 1 ACTIVITY, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, AND METHOD FOR SYNTHESIZING THE SAME | CHINA MEDICAL UNIVERSITY (TW) | 2014-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140221470-A1 | COMPOUND FOR INHIBITING GLUTATHIONE S-TRANSFERASE OMEGA 1 ACTIVITY, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, AND METHOD FOR SYNTHESIZING THE SAME | GSTO1, GSTA1, GSTP1 | LMNA 4056/4885BLM 2013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.